Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
etoricoxib
Merck Sharp & Dohme B.V. Waarderweg 39
M01AH05
etoricoxib
120mg
tablets film-coated
(7/1x7/) in blister, (28/4x7/) in blister
Prescription
Registered
2016-04-19
SUMMARY OF PRODUCT CHARACTERISTICS FOR ARMENIA 1. NAME OF THE MEDICINAL PRODUCT ARCOXIA 2. COMPOSITION One tablet contains: _ACTIVE SUBSTANCE_: 60 mg, 90 mg, 120 mg of etoricoxib. Excipient: 60 mg: lactose 2.7 mg 90 mg: lactose 4.0 mg 120 mg: lactose 5.3 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. _60 mg tablets:_ dark-green, apple-shaped, biconvex film-coated tablets debossed 'ARCOXIA 60' on one side and '200' on the other side. _90 mg tablets: _white, apple-shaped, biconvex film-coated tablets debossed 'ARCOXIA 90' on one side and '202' on the other side. _120 mg tablets:_ pale-green apple-shaped, biconvex film-coated tablets debossed 'ARCOXIA 120' on one side and '204' on the other side. 4. CLINICAL PARTICULARS _4.1 INDICATIONS. _ For the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. For the short-term treatment of moderate pain associated with dental surgery. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks. _ _ _4.2 POSOLOGY AND METHOD OF ADMINISTRATION. _ ARCOXIA is administered orally and may be taken with or without food. The onset of the effect of the medicinal product may be faster when ARCOXIA is administered before meals. This should be considered when rapid symptomatic relief is needed. As the cardiovascular risks of etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis. _Osteoarthritis_ The highest recommended dose is 60 mg once daily. In the absence of an increase in therapeutic benefit, other therapeutic options should be considered. _Rheumatoid arthritis_ The recommended dose is 60 mg or 90 mg once daily. The min Read the complete document